| Alex Morgan, CRNA | |
|
98 Poplar St, Blackfoot, ID 83221-1758 | |
| (208) 313-0924 | |
| Not Available |
| Full Name | Alex Morgan |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 3 Years |
| Location | 98 Poplar St, Blackfoot, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114503745 | NPI | - | NPPES |
| 1114503745 | Medicaid | ID |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bingham Memorial Hospital | Blackfoot, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| East Idaho Anesthesia Associates Pc | 5890957716 | 9 |
News Archive
Providing better care for dual-eligible Medicare-Medicaid patients could significantly reduce hospitalization rates for this population, saving taxpayers between $625 million and $1.9 billion per year, according to a new study by researchers at RTI International and Florida Atlantic University.
Quantum Genomics, a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced the initiation of its Phase IIa multicentric clinical trial of GQC101, entitled QUID HF (QUantum Genomics Incremental Dosing in Heart Failure), for the treatment of patients with chronic heart failure. The first three clinical centres of the European trial have been opened in France and Norway.
Patients faced with a choice of surgical options want to engage their physicians and take a more active role in decision-making, according to a study (abstract 567) released at Digestive Disease Week 2015.
They have revealed a set of pacemaker nerve cells in the brain that appear to underlie the drive to feed which itself feeds on a complex web of signals.
› Verified 1 days ago
| Entity Name | East Idaho Anesthesia Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750651782 PECOS PAC ID: 5890957716 Enrollment ID: O20120509000720 |
News Archive
Providing better care for dual-eligible Medicare-Medicaid patients could significantly reduce hospitalization rates for this population, saving taxpayers between $625 million and $1.9 billion per year, according to a new study by researchers at RTI International and Florida Atlantic University.
Quantum Genomics, a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced the initiation of its Phase IIa multicentric clinical trial of GQC101, entitled QUID HF (QUantum Genomics Incremental Dosing in Heart Failure), for the treatment of patients with chronic heart failure. The first three clinical centres of the European trial have been opened in France and Norway.
Patients faced with a choice of surgical options want to engage their physicians and take a more active role in decision-making, according to a study (abstract 567) released at Digestive Disease Week 2015.
They have revealed a set of pacemaker nerve cells in the brain that appear to underlie the drive to feed which itself feeds on a complex web of signals.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alex Morgan, CRNA Po Box 1627, Idaho Falls, ID 83403-1627 Ph: (208) 552-8778 | Alex Morgan, CRNA 98 Poplar St, Blackfoot, ID 83221-1758 Ph: (208) 313-0924 |
News Archive
Providing better care for dual-eligible Medicare-Medicaid patients could significantly reduce hospitalization rates for this population, saving taxpayers between $625 million and $1.9 billion per year, according to a new study by researchers at RTI International and Florida Atlantic University.
Quantum Genomics, a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced the initiation of its Phase IIa multicentric clinical trial of GQC101, entitled QUID HF (QUantum Genomics Incremental Dosing in Heart Failure), for the treatment of patients with chronic heart failure. The first three clinical centres of the European trial have been opened in France and Norway.
Patients faced with a choice of surgical options want to engage their physicians and take a more active role in decision-making, according to a study (abstract 567) released at Digestive Disease Week 2015.
They have revealed a set of pacemaker nerve cells in the brain that appear to underlie the drive to feed which itself feeds on a complex web of signals.
› Verified 1 days ago
Blake G Purcell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1485 Parkway Dr, Blackfoot, ID 83221 Phone: 208-785-5100 | |
Mr. Ryan T Sayre, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 98 Poplar St, Blackfoot, ID 83221 Phone: 208-785-4100 | |
Jed D Hanks, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 98 Poplar St, Blackfoot, ID 83221 Phone: 208-785-3830 | |
Brandon K Pieper, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 98 Poplar St, Blackfoot, ID 83221 Phone: 208-785-4100 | |
Grant Gundersen, CNRA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 646 W 300 S, Blackfoot, ID 83221 Phone: 208-760-7529 | |
Henry M Adams, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1485 Parkway Dr, Blackfoot, ID 83221 Phone: 208-785-5100 | |
Zachary D Morrow, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 98 Poplar St, Blackfoot, ID 83221 Phone: 208-785-4100 |